When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CNST - Constellation Pharmaceuticals: Post Fundraising Dip Is A Buy Opportunity
Constellation Pharmaceuticals Inc.
Investment Thesis
Constellation Pharmaceuticals share price performance since IPO. Source: TradingView.
Since launching a scaled-down IPO in July 2019 at $15 per share that raised ~$60m - as opposed to the $80m it had originally sought - Constellation Pharmaceuticals (CNST) has delivered outstanding results for its shareholders.
The epigenetics specialist has put together a small but promising pipeline of small molecule inhibitors targeting a rare form of blood cancer, Myelofibrosis, as well as solid tumor treatments.
The major catalyst for Constellation's share price growth from a low of $6 to a mid-May